Xtant Medical Holdings, Inc. Announces Expiration of Rights Offering
June 19, 2018 08:00 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, MT, June 19, 2018 (GLOBE NEWSWIRE) -- XtantTM Medical Holdings, Inc. (NYSE American: XTNT) announces that the subscription period for its previously announced rights offering (the...
Xtant™ Medical To Present at ICV Manhattan Conference
December 03, 2015 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Dec. 03, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative...
Xtant Medical Holdings, Inc. Reports Third Quarter 2015 Results
November 11, 2015 16:27 ET
|
Xtant Medical Holdings, Inc.
Third Quarter 2015 Consolidated Pro Forma Highlights: Consolidated pro forma revenue increased 6.5% to $20.9 million from $19.6 million in the third quarter of 2014. Excluding OEM revenue,...
Xtant Medical Announces First Surgical Use of OsteoSelect® PLUS DBM Putty
November 03, 2015 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced...